BOSTON SCIENTIFIC CORP is 2.5x more valuable than DEXCOM INC by market capitalization ($71.85 B vs $28.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BSX | DXCM |
|---|---|---|
| Market cap | $71.85 B | $28.97 B |
| US-listed rank | #236 | #474 |
| Revenue (latest FY) | $20.07B | $4.66B |
| Net income (latest FY) | - | $836.30M |
| Net margin | - | 17.9% |
| P/E (trailing FY) | - | 34.6 |
| SEC filings | 1,009 | 2,566 |
BOSTON SCIENTIFIC CORP is 2.5x more valuable than DEXCOM INC by market capitalization ($71.85 B vs $28.97 B).
In their latest fiscal years, BOSTON SCIENTIFIC CORP reported $20.07B in revenue while DEXCOM INC reported $4.66B.
Full pages: BOSTON SCIENTIFIC CORP and DEXCOM INC, or browse the full rankings.